The ETV6 gene helps control when other genes turn on and off, especially as blood cells develop. If it does not work properly, the body may make too few platelets, the blood cells that help clot, which can lead to easy bruising, nosebleeds, or heavier bleeding. The protein made by this gene helps your cells grow in a more controlled way. Certain inherited ETV6 variants can run in families and may also raise the chance of blood cancers such as leukemia.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do much of the work. Other genes mostly help regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. To explore this subject in more detail, you can learn more in the LearnHub.
Overview
ETV6Gene function
What if the gene works
The ETV6 gene helps control how other genes turn on and off, especially during blood cell development. It supports normal bone marrow function and helps keep cell growth orderly.
Risk
What if the gene does not work
When the ETV6 gene does not work properly, low platelet counts with easy bruising or nosebleeds are common, and blood cancer risk, especially leukemia, can be higher. Milder or more severe variants can influence timing and severity.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by pathogenic variants in the ETV6 gene. In research, the ETV6 gene is studied mainly as a cancer biomarker and driver, especially in leukemia and some fusion positive tumors.
Conditions associated with ETV6
Gene function
What if the gene works
Healthy blood cell production depends on carefully timed gene signals. The ETV6 gene helps keep those signals organized, especially in bone marrow where new blood cells are made. Its work supports normal cell growth, steady blood stem cells, and orderly cell maturation.
The ETV6 gene helps switch certain genes on or off at the right time. This keeps cell programs balanced as cells grow and take on specific jobs.
In bone marrow, the ETV6 gene supports blood forming stem cells as they renew themselves and begin to specialize. This steady control is a core part of ETV6 gene function in everyday blood cell production.
Its protein helps cells respond to growth signals in a measured way. This supports normal cell division and orderly maturation.
What is a variant?
A genetic variant is a slight change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In understanding how variants in the ETV6 gene affect blood cell development, the problem is a weaker or misdirected ETV6 protein. Some variants reduce how well it attaches to DNA, make the protein unstable, keep it out of the cell nucleus, or block the normal copy from working. Milder variants may leave partial activity, while more disruptive variants can cause greater loss of function and may be linked to earlier or greater platelet changes and, in some families, leukemia risk.
How variants are linked to conditions
Pathogenic variants in the ETV6 gene cause an inherited condition with lifelong low platelet counts, often called ETV6-related thrombocytopenia. This may lead to easy bruising or nosebleeds and can also raise the risk of blood cancers, especially childhood acute lymphoblastic leukemia. Some families with an ETV6 gene variant linked to leukemia and low platelets also include people with acute myeloid leukemia or myelodysplastic syndrome.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widely found across the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. Still, in some situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
A disease-causing change in the ETV6 gene can raise the chance of lifelong low platelets and some blood cancers, but specific lifestyle or environmental factors that clearly increase or lower that risk have not been firmly established. Anyone with concerns about their personal or family risk should speak with a doctor or genetic counselor.
Inheritance of ETV6 variants
ETV6-related conditions are usually inherited in an autosomal dominant pattern. In practical terms, inheritance of the ETV6 gene variants means a person only needs one changed copy of the gene to have the condition or related cancer risk, and an affected parent can pass it to a child of any sex with a 50% chance in each pregnancy. Sons and daughters are affected at similar rates, and either parent can pass the variant on.
What does my ETV6 result mean for my family?
For ETV6, the family pattern is usually dominant, which means close relatives such as parents, brothers, sisters, and children may also carry the same change. In many families, this is linked to lifelong low platelets and a higher chance of certain blood cancers. Because of that, a result in one person can be important information for the wider family as well.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for ETV6 variants uses a blood sample or saliva sample to read the ETV6 gene and check for small spelling changes and, in some labs, missing or extra pieces. Results can show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider testing for changes in the ETV6 gene if you or close relatives have had lifelong low platelet counts, easy bruising or nosebleeds, or blood cancers such as leukemia, especially when these run in the family. Testing can help clarify whether these problems are linked and whether relatives may also carry the same gene change.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, but how much they reveal varies with the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly, which can change how much of the medicine reaches the body over time. This is one reason the same treatment may work well for one person but less well for another, or cause more side effects in some people. These differences are common and can influence both how effective a medicine is and how sensitive someone may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medicines. It studies links between genes and medications to help explain why the same treatment can work differently in different people. For many drugs, genes influence how strongly a medicine works or how the body handles it. This information can support more informed, more personalized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the ETV6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how most medicines will work or what side effects they may cause, so general medication or health concerns are best discussed with your doctor. ETV6 has mainly been studied in cancer-related gene changes, where tumor findings can sometimes help guide treatment discussions in certain cancers rather than routine inherited drug-response care.
History
The ETV6 gene entered medical genetics through cancer research in the 1990s, when scientists studying leukemia repeatedly found chromosome swaps involving this region. It was first described as TEL, and later renamed ETV6 as gene naming became more standardized. Building on this early work, scientists linked ETV6 changes to several blood cancers, making it an important marker in leukemia research. Later, inherited variants in the ETV6 gene were also recognized in some families with low platelet counts and a higher chance of certain blood conditions. These discoveries helped connect older chromosome findings with modern DNA based testing.